[1] |
Cox HS, Niemann S, Ismailov G , et al. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Clin Infect Dis, 2007,44(11):1421-1427.
doi: 10.1086/517536
URL
pmid: 17479936
|
[2] |
World Health Organization. Global tuberculosis report 2015. Geneva:World Health Organization, 2015.
|
[3] |
Keshavjee S, Farmer PE . Tuberculosis,drug resistance,and the history of modern medicine. N Engl J Med, 2012,367(10):931-936.
doi: 10.1056/NEJMra1205429
URL
|
[4] |
World Health Organization. Global tuberculosis report 2016. Geneva:World Health Organization, 2016.
|
[5] |
许宾, 孙加源, 黄燕 . 综合医院肺外结核101例临床分析. 中国防痨杂志, 2004,26(3):151-154.
doi: 10.3969/j.issn.1000-6621.2004.03.008
URL
|
[6] |
Yoon HJ, Song YG, Park WI , et al. Clinical manifestatians and diagnosis of extrapulmonary tuberculosis. Yonsei Med J, 2004,45(3):453-461.
doi: 10.3349/ymj.2004.45.3.453
URL
pmid: 15227732
|
[7] |
李强, 董伟杰, 范俊 , 等. 38例骨关节结核患者病灶标本分枝杆菌培养及药物敏感性试验结果分析. 中国防痨杂志, 2017,39(3):277-281.
doi: 10.3969/j.issn.1000-6621.2017.03.015
URL
|
[8] |
张娟, 蒋俊, 张红 , 等. MGIT960 与罗氏培养法在结核分枝杆菌培养及药敏试验中的比对分析. 中国防痨杂志, 2011,33(6):361-365.
|
[9] |
许宏涛, 陈东科, 赖惠英 . 结核分枝杆菌四种常用方法检测比较. 中国热带医学, 2015,15(5):612-614.
|
[10] |
范顺武, 胡子昂 . 重视脊柱结核化学药物治疗的重要性. 中国骨伤, 2017,30(9):783-786.
doi: 10.3969/j.issn.1003-0034.2017.09.001
URL
|
[11] |
Tan Y, Li Q, Wang Q , et al. Evaluation of the MTBDRplus 2.0 assay for the detection of multidrug resistance among persons with presumptive pulmonary TB in China. Sci Rep, 2017,7(1):3364.
doi: 10.1038/s41598-017-03473-7
URL
pmid: 28611407
|
[12] |
Rufai SB, Kumar P, Singh A , et al. Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis. J Clin Microbiol, 2014,52(6):1846-1852.
doi: 10.1128/JCM.03005-13
URL
pmid: 4042801
|
[13] |
Wang G, Dong W, Lan T , et al. Diagnostic accuracy evaluation of the conventional and molecular tests for spinal tuberculosis in a cohort, head-to-head study. Emerg Microbes Infect, 2018,7(1):109.
doi: 10.1038/s41426-018-0114-1
URL
|
[14] |
Li Y, Jia W, Lei G , et al. Diagnostic efficiency of Xpert MTB/RIF assay for osteoarticular tuberculosis in patients with inflammatory arthritis in China. PLoS One, 2018,13(6):e0198600.
doi: 10.1371/journal.pone.0198600
URL
pmid: 29856840
|
[15] |
穆晶, 赵丹, 董宇杰 , 等. 结核病病理学诊断的研究进展与临床应用. 结核病与肺部健康杂志, 2017,6(4):386-390.
|
[16] |
Valafar F .Pathogenesis of multi drug-resistant and extensively drug-resistant tuberculosis as a determinant of future treatment success.Int J Mycobacteriol, 2016,5 Suppl 1: S64-65.
doi: 10.1016/j.ijmyco.2016.11.017
URL
pmid: 28043618
|
[17] |
Rahman MA, Sarkar A . Extensively drug-resistant tuberculosis (XDR-TB):A daunting challenge to the current End TB Strategy and policy recommendations. Indian J Tuberc, 2017,64(3):153-160.
doi: 10.1016/j.ijtb.2017.03.006
URL
|
[18] |
秦世炳 . 重视结核病诊治和脊柱结核手术时机的选择. 中国骨伤, 2013,26(7):533-535.
doi: 10.3969/j.issn.1003-0034.2013.07.001
URL
|
[19] |
Pang Y, Lu J, Huo F ,et al.Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China:A five-year review. J Infect, 2017,75(5):433-440.
doi: 10.1016/j.jinf.2017.08.005
URL
pmid: 28804028
|
[20] |
World Health Organization. Treatment guidelines for drug-resistant tuberculosis,2016 update. Geneva:World Health Organization, 2016.
URL
pmid: 27748093
|
[21] |
宋向伟, 梁强, 马文鑫 , 等. 影响脊柱结核术后超短程化疗方案的因素分析. 中国矫形外科杂志, 2018,26(2):144-149.
doi: 10.3977/j.issn.1005-8478.2018.02.10
URL
|
[22] |
姚晓伟, 董昭良, 李卓 , 等. 60例耐药脊柱结核患者个体化治疗及疗效的临床研究. 中国防痨杂志, 2016,38(11):978-984.
doi: 10.3969/j.issn.1000-6621.2016.11.017
URL
|
[23] |
习昕 . 肺外结核514例临床分析. 广州:中山大学, 2006.
|
[24] |
牟朋林, 陈克冰, 杨建惠 . 脊柱结核术后复治的危险因素Logistic回归分析. 现代医院, 2018,18(5):719-721,724.
|
[25] |
秦世炳 . 重视肺外结核病并规范骨关节结核的临床诊治. 中国防痨杂志, 2014,36(8):655-658.
doi: 10.3969/j.issn.1000-6621.2014.08.011
|
[26] |
马远征 . 进一步提高脊柱结核的治疗效果. 中国脊柱脊髓杂志, 2010,20(10):795-796.
doi: 10.3969/j.issn.1004-406X.2010.10.02
URL
|
[27] |
马远征, 李大伟, 胡明马 , 等. 耐药脊柱结核个体化诊疗模式应用研究//中华医学会骨科分会.中华医学会第十四届骨科学术会议暨第七届COA国际学术大会资料汇编. 北京:中华医学会骨科分会, 2012.
|
[28] |
许建中 . 规范脊柱结核治疗,为我国结核病防治做出更大贡献. 中华骨科杂志, 2014,34(2):97-101.
doi: 10.3760/cma.j.issn.0253-2352.2014.02.001
|
[29] |
张宏其 . 如何全面认识和规范应用单纯经后路病灶清除椎体间植骨术治疗脊柱结核. 中国矫形外科杂志, 2018,26(2):97-100.
|
[30] |
蒋之, 屈满英, 万轲 . 耐药脊柱结核的临床分析及疗效研究. 中国现代医学杂志, 2016,11(6):132-136.
doi: 10.3969/j.issn.1005-8982.2016.11.029
URL
|
[31] |
李大伟, 马远征, 李力韬 , 等. 脊柱结核伴截瘫外科治疗的疗效分析. 中华骨科杂志, 2014,34(2):156-161.
doi: 10.3760/cma.j.issn.0253-2352.2014.02.010
URL
|
[32] |
张宏其, 陈筱, 郭虎兵 , 等. 单纯后路病灶清除椎体间植骨融合内固定治疗脊柱结核的适应证及疗效评价. 中国矫形外科杂志, 2012,20(3):196-199.
doi: 10.3977/j.issn.1005-8478.2012.03.02
URL
|